Onego Bio
Helsinki
About Onego Bio
Onego Bio is a food ingredient company on a mission to create a more resilient food system through its product Bioalbumen®’the first non-animal egg protein with an amino acid sequence identical to the natural protein. Made through precision fermentation, Bioalbumen® matches the nutrition and functionality of traditional eggs while delivering greater supply stability, consistent pricing, and 90% lower environmental impact. With a proven industrial-scale process, FDA GRAS status, and technological development that advances positive unit economics, Onego Bio is addressing the $300BN egg market by helping food manufacturers meet rising demand for reliable protein without compromising on performance. From baked goods to sauces and ready-to-eat meals, Bioalbumen® fits seamlessly into existing formulations’making the transition to smarter proteins easier than ever.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $72.6M
- Last round: Grant (Oct 2024)
- Website: onego.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Food and Beverage, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/onego-bio-93470 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.